Who we are
We are experts in our field and leaders in the Disclosures space, actively participating in global working groups that are helping to shape and define the Clinical Trial Transparency landscape now and for the future. 
It's our job to keep our fingers on the pulse of the Regulatory environment, and it's our goal to help our clients meet their Disclosures obligations quickly, cost effectively and to the highest standard.
Our strength is in our flexibility, our indepth knowledge, and our technical know-how. We can structure complete or supplemental outsourcing of Disclosures activities, provide management consulting, and deliver technology-driven solutions to suit each sponsor's needs.
The Xogene team goes above and beyond meeting even the most challenging of deadlines. They consistently deliver excellent quality work
Global Head of Disclosures
Top 5 pharmaceutical company
Our Vision
Specialized knowledge

Our vision reflects the ethics and principles of the community in which we work. Our focus is supporting those organizations whose core concern is the welfare of patients and trial participants.


Xogene upholds the highest standards of open and honest communication with our clients and partners and strives for continued knowledge sharing and process improvement, while respecting and protecting confidential information.

Innovative Technology 
Flexible working model
The Team
Paul Ngai, M.S.
As Co-founder and CEO, Paul leads Xogene's strategic direction as well as provides direct oversight of the Disclosure and Outsourcing Services practice.
A veteran in the field of clinical trial registration and disclosure, Paul has been working in the life sciences area since 2006 and has over 25 years of experience in technology management.
Paul's consulting career spanned technology and project management including clinical disclosure and management consulting within the pharmaceutical industry.   He received both his bachelor and Master's degree from Stevens Institute of Technology. 

Co-founder &
Chief Executive Officer
Woo Song
As a seasoned technology entrepreneur and business builder, Woo oversees products and platform services for Xogene.
Prior to Xogene, Woo co-founded Intrasphere, a technology and services provider to the biopharmaceutical industry, which was acquired by Deloitte Consulting. Woo also co-founded PharmaCM, a leading clinical disclosure platform, now acquired by TrialScope.

A former derivatives trader, Woo is also a founder of Reval, a global leader of SaaS platform for treasury and risk management with clients and employees in North America, EMEA and Asia Pacific.
Co-founder &
Chief Product Officer